|
Spencer Technologies’ Mark Moehring,
Ph.D. to Present Embolus Characterization Data at Summer in Seattle
SEATTLE, WA – July
19, 2004 –
Spencer Technologies announced today that Mark Moehring,
Ph.D. will present his recent results of Embolus Characterization
Using Harmonic Doppler on Wednesday, July 21st at the
Emerging Technologies Symposium, which is part of the Summer in Seattle
Interventional Cardiac and Vascular Therapies Course.
Dr.
Moehring is using Spencer Technologies’ digital Power M-Mode Doppler (PMD)
to characterize microemboli as gaseous or solid (formed element).
Microemboli can potentially obstruct blood flow, at least temporarily,
in the terminal branches of arteries and/or in the microcirculation.
Microemboli have also been associated with stroke, heart attacks,
peripheral arterial diseases, deep venous thrombosis which can result in
pulmonary embolism, and procedures such as cardiovascular surgery and
catheterizations.
Characterizing microemboli can be important for clinical management of
patients when the source underlying cause is ambiguous. Utilizing PMD
to differentiate microembolus composition is projected to be a vital
tool in determining when and which therapies are appropriate.
“A
national forum like Summer in Seattle is a great venue to hear valuable
critique, as well as stimulating discussion on technologies in their
early stages,” stated Dr. Moehring, V.P. of Research & Development at
Spencer Technologies.
About Mark Moehring, Ph.D.
Dr.
Moehring has worked with the Spencer team both at Spencer Technologies
and the Institute of Applied Physiology and Medicine since 1983.
He has been granted seven patents and has published dozens of articles
in scientific journals. Dr. Moehring leads the Spencer
Technologies research and development team, and is a co-inventor on the
Company's patents. He has more than 20 years experience in Doppler
ultrasound engineering for a number of cardiovascular applications.
About Spencer Technologies
Spencer Technologies was co-founded in 1992 by Dr. Merrill Spencer, a
pioneer in the development of diagnostic ultrasound. Spencer
Technologies is dedicated to preventing a variety of adverse
cardiovascular related events, including strokes, and significantly
improving healthcare through the development and use of non-invasive
ultrasound technologies for diagnosis, monitoring, and therapeutic
effects. Spencer Technologies is involved in all aspects of ultrasound
through integrated patient services, clinical research, R & D,
manufacturing, and marketing their products and services.
|
